Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson’s Disease

Verma, A. K., Raj, J., Sharma, V., Singh, T. B., Srivastava, S., & Srivastava, R. (2015). Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's Disease. Parkinson＇s Disease, 2015(), 492-497. https://doi.org/10.1155/2015/598028
Dumitriu, A., Moser, C., Hadzi, T. C., Williamson, S. L., Pacheco, C. D., Hendricks, A. E., Latourelle, J. C., Wilk, J. B., DeStefano, A. L., & Myers, R. H. (2012). PostmortemInterval Influences α-Synuclein Expression in Parkinson Disease Brain. Parkinson＇s Disease, 2012(), 472-479. https://doi.org/10.1155/2012/614212
Mounsey, R. B., & Teismann, P. (2011). Mitochondrial Dysfunction in Parkinson’s Disease: Pathogenesis and Neuroprotection. Parkinson＇s Disease, 2011(), 517-534. https://doi.org/10.4061/2011/617472
Sekiyama, K., Sugama, S., Fujita, M., Sekigawa, A., Takamatsu, Y., Waragai, M., Takenouchi, T., & Hashimoto, M. (2012). Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies. Parkinson＇s Disease, 2012(), 159-166. https://doi.org/10.1155/2012/271732
Farooqui, T., & Farooqui, A. A. (2011). Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson’s Disease. Parkinson＇s Disease, 2011(), 174-182. https://doi.org/10.4061/2011/247467